Devoted Health
PrivateLast Round
Series G
Oct 1, 2026
Est. Valuation
$25B
Total Funding Raised
$3.59B
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Devoted Health is a healthcare company that offers Medicare Advantage plans and personalized medical services to improve the health and well-being of older Americans.
Sector
Healthcare & Life Sciences
Verticals
InsurTech, Telemedicine, Patient Engagement, Healthcare Analytics
Business Model
B2C
Customer Profile
Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Devoted Health Comparables
Compare Devoted Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alignment Healthcare | 86% | |
| Clover Health | 84% | |
| Zing Health | 80% |
Devoted Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series G | Oct 1, 2026 | ||||
| Series F Extension | Jan 30, 2026 | ||||
| Series F | Nov 1, 2025 | ||||
| Series E Extension | Aug 2, 2024 | ||||
| Series E | Dec 29, 2023 | ||||
Series D | Oct 8, 2021 |
Key People
Founding team and executive leadership
Devoted Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series D, Series E, Series F, Series F Extension, Series C, Series G, Series B |
| GreatPoint Ventures | Series E |
| VanEck | Series F, Series F Extension |
| S32 | Series D, Series C |
| SoftBank Investment Advisers | Series D |
| Formica Capital | Series D |
| VZVC | Series F, Series F Extension, Series G |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2026
$555M round led by Advent International and Temasek.
- Apr 21, 2026
Developing 'Everyday Care' model merging primary and virtual care.
Recent news
Latest coverage and updates
- recognized_asOct 16, 2026
U.S. News names Devoted among the best Medicare Advantage companies in its 2026 edition.
- expands_offices_toOct 5, 2026
Devoted plans to expand into Michigan in 2027
- expands_offices_toOct 5, 2026
Devoted plans to expand into New Jersey in 2027
- expands_offices_toOct 5, 2026
Devoted expands into New Hampshire in 2027
- partners_withOct 5, 2026
Devoted partners with Walmart Inc. in a co-branded Medicare Advantage partnership
Devoted Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessAppears On
Curated lists and screens where this company is featured.
Frequently Asked Questions
Common questions about Devoted Health's valuation, stock price, and market status.
Is Devoted Health a public or private company?
Devoted Health is a private company.
What is the current stock price of Devoted Health?
Devoted Health is a private company, so its shares have no public market price. Caplight tracks Devoted Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Devoted Health worth (valuation)?
Devoted Health's valuation is estimated at $25.0B based on funding round data.
Can I buy Devoted Health stock?
Devoted Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Devoted Health's last funding round?
Devoted Health's most recent funding round was Series G on October 1, 2026.
Who are the main investors in Devoted Health?
Key investors in Devoted Health include Andreessen Horowitz, SoftBank Investment Advisers, Temasek, Maverick Ventures, Oak HC/FT.
Will Devoted Health IPO soon?
No public IPO plans have been announced for Devoted Health.
How can I track Devoted Health secondary market activity?
Caplight tracks bids, offers, and trades in Devoted Health's shares on secondary markets.